About Us
Group Profile
Introduction
Mission
History
Honor
Brand Interpretation
Vision
Development
Party Affairs
Material Download
Innovation
Biologics
Small Molecule(s)
Innovative Technology
Ongoing Projects
R & D Team
Capabilities
Core Competence
Platform Enterprise
Management System
Products
Rx
Renal
Oncology
Cardiovascular
Respiratory
Pain
OTC
News
Company Release
Media Coverage
Information Disclosure
Adverse Drug Reaction Reporting Platform
Public Notice of Pharmaceutical Representative Record (Third Party Website)
Product Traceability
Enterprise Announcement
CSR
Responsibility Bearng
Social Welfare
CSR Report
Talents
Talent Management
Enterprise University
Join Us
medicine
medicine
Clean energy
Investment
EN
/
CN
Medicine
Medicine
Clean energy
Investment
Respiratory
首页
Respiratory
氢化泼尼松
国药准字:H36022366、H36022365医保:国家医保目录乙类品种适应症:肾上腺皮质激素类药。具有影响糖代谢、抗炎、抗过敏、抗毒等作用。用于肾上腺皮质功能减退症,活动性风湿病、类风湿性关节炎、全身性红斑狼疮等胶元性疾病、严重的支气管哮喘、皮炎、过敏性疾病、急性白血病及感染性休克等。简介:全科用药,适应症广;起效迅速,抗炎作用强;疗效确切,安全性更高;水钠潴留少,对HPA轴抑制弱。
Related literature
Related Consensus